Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer

Abstract

Vitamin D and the vitamin D receptor (VDR) complex have been reported to inhibit the growth of several types of tumor; however, their function in papillary thyroid cancer (PCT) remains unknown.

In addition, the Wnt/β‑catenin signaling pathway was discovered to serve a critical role in the pathology of PCT.

Therefore, the present study aimed to determine the role of the VDR and its association with Wnt/β‑catenin signaling in vitamin D‑treated PTC cells. VDR expression was detected in human PTC cells (including MDA‑T120, MDA‑T85, SNU‑790 and IHH4 cells) and thyroid follicular cells (Nthy‑ori 3‑1 cells). SNU‑790 and IHH4 cells were infected with KD‑VDR or negative control (KD‑NC) lentiviruses, treated with 1,25(OH)2D3 (the active form of vitamin D), and subsequently referred to as the KD‑VDR&vitD and KD‑NC&vitD groups, respectively.

Additionally, PTC cells infected with KD‑NC and not treated with 1,25(OH)2D3 were used as the normal control and referred to as the KD‑NC group. VDR mRNA and protein expression levels were increased in MDA‑T120, SNU‑790 and MDA‑T85 cells compared to Nthy‑ori 3‑1 cells, whereas in IHH4 cells, VDR mRNA and protein expression levels were similar to Nthy‑ori 3‑1 cells.

In SNU‑790 and IHH4 cells, cell proliferation and invasion were decreased in the KD‑NC&vitD group compared with the KD‑NC group, but increased in the KD‑VDR&vitD group compared with the KD‑NC&vitD group.

Cell apoptosis was increased in the KD‑NC&vitD group compared with the KD‑NC group, and decreased in the KD‑VDR&vitD group compared with the KD‑NC&vitD group.

Furthermore, the expression levels of Wnt family member 3 and catenin β1 were decreased in the KD‑NC&vitD group compared with the KD‑NC group, but increased in the KD‑VDR&VitD group compared with the KD‑NC&vitD group.

In conclusion, the present study revealed that VDR‑KD attenuated the antiproliferative, pro‑apoptotic and anti‑invasive effects of vitamin D in PTC by activating the Wnt/β‑catenin signaling pathway.

About this publication.

See also:

- Official Web Site: The Di Bella Method;

- The Di Bella Method (A Fixed Part - Dihydrotachysterol, Alfacalcidol, synthetic Vitamin D3);

- Vitamin D (analogues and/or derivatives) and cancer - In vitro, review and in vivo publications;

- The Di Bella Method DBM improved survival objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck;

- Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status;

- Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status;

- Observations on the Report of a case of pulmonary adenocarcinoma with lymph node, hepatic and osseus metastasis;

- Pleural Mesothelioma: clinical records on 11 patients treated with Di Bella's Method;

- Malignant pleural mesothelioma, stage T3-T4. Consideration of a case study;

- Excellent result in a Mesothelioma case treated exclusively with Di Bella Method for over 4 years and still treatment with positive results;

- Neuroblastoma: Complete objective response to biological treatment;

- Oesophageal squamocellular carcinoma: a complete and objective response;

- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;

- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer;

- The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature;

- The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer;

- Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast;

- Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report;

- The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer;

- Complete objective response to biological therapy of plurifocal breast carcinoma;

- Recurrent Glioblastoma Multiforme (grade IV – WHO 2007): a case of complete objective response achieved by means of the concomitant administration of Somatostatin and Octreotide – Retinoids – Vitamin E – Vitamin D3 – Vitamin C – Melatonin – D2 R agonists (Di Bella Method – DBM) associated with Temozolomide.